ReviewJournal of hematology & oncology2026

CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality.

Leila Omidvar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.